Company information
- Ticker
- 6496
- Country
- Taiwan
- Sector
- Health Care
- Industry
- Biotech
Excelsior Business Summary
Excelsior Medical Co., Ltd. (6496.TWO) operates a vertically integrated healthcare distribution and service model, primarily generating revenue through the sale, leasing, and maintenance of specialized medical equipment and consumables. The company’s operations are structured into four primary segments: Excelsior (core medical distribution), Dynamic (logistics and management), Arich (pharmaceuticals and supplies), and Others (beauty and lifestyle products). Its high-density product portfolio is anchored in the renal care sector, featuring hemodialysis and plasma exchange systems, artificial kidneys, and dialysis machines, alongside surgical consumables and home health appliances. Excelsior maintains a leading market position in Taiwan and has established a significant regional presence in Hong Kong, China, and Southeast Asia. It competes directly with major industry players such as Pacific Hospital Supply (PAHSCO), B. Braun, and Fresenius Medical Care, distinguishing itself through a comprehensive service ecosystem that integrates technical maintenance and medical management consultancy with product distribution. Founded in 1988 as Enfield Medical Co. Ltd. and rebranded in 2009, the company is currently led by Chairman Chen Tun-Ling, who serves as the representative for the primary institutional shareholder, Excelsior Group Holdings Co., Ltd. The executive management team is headed by CEO Chang Ming-Cheng, a veteran director with deep expertise in medical supply chain logistics and strategic regional expansion. The leadership is supported by a stable board of directors, including key figures such as Fu Hui-Tung and Fu Jo-Hsuan, who bring decades of experience in the Taiwanese healthcare market. The company’s ownership structure is characterized by strong institutional backing from entities such as Excelsior Group Holdings, Jiahe Investment, and Xuanhui Investment, providing a robust capital foundation for its ongoing diversification into medical beauty and high-precision healthcare instruments.